Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED, Stock Code: 03347) convened its 2026 First Extraordinary General Meeting (EGM) on March 5, 2026. The chairman of the board, together with all seven directors, participated in person or via video conference. Based on polling, the special resolution concerning the proposed change of registered address and corresponding amendments to the company’s Articles of Association was duly passed.

The total number of issued shares stood at 861.03 million, of which 5.88 million were treasury A Shares that abstained from voting. Consequently, 855.14 million shares were entitled to vote. Shareholders holding 431.26 million shares, representing approximately 50.43% of the total voting rights, participated in person, by proxy, or via network voting. Of those, 383.34 million shares comprised A Shares, accounting for around 44.83% of all voting shares, while 47.91 million shares were H Shares, making up about 5.60%.

In the final poll results, over two-thirds of votes were cast in favor of the special resolution. As confirmed by the scrutineers and legal advisor present, the EGM was duly convened and complied with all relevant laws, regulations, and the company’s Articles of Association. The resolution was officially approved as a special resolution of the company.